BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21084557)

  • 1. Long-term statin use and the risk of gallstone disease: A population-based case-control study.
    Erichsen R; Frøslev T; Lash TL; Pedersen L; Sørensen HT
    Am J Epidemiol; 2011 Jan; 173(2):162-70. PubMed ID: 21084557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and the risk of gallstone disease: a population-based case-control study.
    Chiu HF; Chen CC; Kuo HW; Lee IM; Wu TN; Yang CY
    Expert Opin Drug Saf; 2012 May; 11(3):369-74. PubMed ID: 22243480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the risk of acute pancreatitis: a population-based case-control study.
    Thisted H; Jacobsen J; Munk EM; Nørgaard B; Friis S; McLaughlin JK; Sørensen HT; Johnsen SP
    Aliment Pharmacol Ther; 2006 Jan; 23(1):185-90. PubMed ID: 16393296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and risk of gallstone disease followed by cholecystectomy.
    Bodmer M; Brauchli YB; Krähenbühl S; Jick SS; Meier CR
    JAMA; 2009 Nov; 302(18):2001-7. PubMed ID: 19903921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
    Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
    Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin administration and risk of cholecystectomy: a population-based case-control study.
    Merzon E; Weiss NS; Lustman AJ; Elhayani A; Dresner J; Vinker S
    Expert Opin Drug Saf; 2010 Jul; 9(4):539-43. PubMed ID: 20482330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.
    Christiansen CF; Christensen S; Mehnert F; Cummings SR; Chapurlat RD; Sørensen HT
    Arch Intern Med; 2009 Oct; 169(18):1677-83. PubMed ID: 19822824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients.
    Thomsen RW; Riis A; Kornum JB; Christensen S; Johnsen SP; Sørensen HT
    Arch Intern Med; 2008 Oct; 168(19):2081-7. PubMed ID: 18955636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for statin-associated rhabdomyolysis.
    Schech S; Graham D; Staffa J; Andrade SE; La Grenade L; Burgess M; Blough D; Stergachis A; Chan KA; Platt R; Shatin D
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):352-8. PubMed ID: 16892458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin Use and Risk of Atrial Fibrillation or Flutter: A Population-based Case-Control Study.
    Veronese G; Montomoli J; Schmidt M; Horváth-Puhó E; Sørensen HT
    Am J Ther; 2015; 22(3):186-94. PubMed ID: 23567792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and risk of cholecystectomy - A case-control analysis using Swiss claims data.
    Biétry FA; Reich O; Schwenkglenks M; Meier CR
    Expert Opin Drug Saf; 2016 Dec; 15(12):1577-1582. PubMed ID: 27677561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and risk of epilepsy: a nested case-control study.
    Etminan M; Samii A; Brophy JM
    Neurology; 2010 Oct; 75(17):1496-500. PubMed ID: 20975051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.
    Simonsen MH; Erichsen R; Frøslev T; Rungby J; Sørensen HT
    Drug Saf; 2013 Dec; 36(12):1189-97. PubMed ID: 24174288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tea consumption and risk of biliary tract cancers and gallstone disease: a population-based case-control study in Shanghai, China].
    Zhang XH; Gao YT; Rashid A; Deng J; Liu EJ; Wu K; Sun L; Cheng JR; Gridley G; Hsing AW
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):667-71. PubMed ID: 16438888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and newly diagnosed diabetes.
    Jick SS; Bradbury BD
    Br J Clin Pharmacol; 2004 Sep; 58(3):303-9. PubMed ID: 15327590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering drugs and the risk of depression and suicidal behavior.
    Yang CC; Jick SS; Jick H
    Arch Intern Med; 2003 Sep; 163(16):1926-32. PubMed ID: 12963565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.